MBOT logo

MBOT
Microbot Medical Inc

17,687
Mkt Cap
$136.34M
Volume
3.64M
52W High
$4.67
52W Low
$1.60
PE Ratio
-7.34
MBOT Fundamentals
Price
$2.03
Prev Close
$1.93
Open
$1.94
50D MA
$2.20
Beta
1.53
Avg. Volume
1.55M
EPS (Annual)
-$0.287
P/B
1.84
Rev/Employee
$0.00
$13.85
Loading...
Loading...
News
all
press releases
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks
News Placeholder
More News
News Placeholder
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday
Microbot Medical (NASDAQ:MBOT) will be releasing earnings after the market closes on Wednesday, May 13. (View Earnings Report at...
MarketBeat
News Placeholder
Cencora to Report Q2 Earnings: What's in Store for the Stock?
COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.
Zacks
News Placeholder
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?
SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
Zacks
News Placeholder
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.
Zacks
News Placeholder
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.
Zacks
News Placeholder
Revvity to Report Q1 Earnings: What's in Store for the Stock?
RVTY heads into Q1 earnings with Diagnostics strength and Life Sciences stabilization, but China pressures and weak academic demand may temper near-term growth.
Zacks
News Placeholder
Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen
Wall Street Zen downgraded Microbot Medical from a "sell" rating to a "strong sell" rating in a research note on Saturday...
MarketBeat
News Placeholder
Stryker to Report Q1 Earnings: What's in Store for the Stock?
SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.
Zacks
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available